TrialMolecular psychiatry2014

Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.

G Sanacora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.